BioNTech SE (BNTX)
86.47
+0.97
(+1.13%)
USD |
NASDAQ |
Jun 09, 16:00
86.05
-0.42
(-0.49%)
After-Hours: 20:00
BioNTech SG&A Expense (Quarterly) : 176.43M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Moderna, Inc. | 173.00M |
| NuCana Plc | 2.113M |
| MediGene AG | -- |
| InflaRx NV | 3.844M |
| Mereo BioPharma Group Plc | 4.012M |